BR0207302A - Trifluorometilpurinas como inibidores da fosfodiesterase 4 - Google Patents
Trifluorometilpurinas como inibidores da fosfodiesterase 4Info
- Publication number
- BR0207302A BR0207302A BR0207302-1A BR0207302A BR0207302A BR 0207302 A BR0207302 A BR 0207302A BR 0207302 A BR0207302 A BR 0207302A BR 0207302 A BR0207302 A BR 0207302A
- Authority
- BR
- Brazil
- Prior art keywords
- phosphodiesterase
- inhibitors
- trifluoromethylpurines
- trifluorometilpurins
- formula
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/40—Heterocyclic compounds containing purine ring systems with halogen atoms or perhalogeno-alkyl radicals directly attached in position 2 or 6
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Abstract
"TRIFLUOROMETILPURINAS COMO INIBIDORES DA FOSFODIESTERASE 4. A inibição da PDE4 é obtida por novos compostos da fórmula (I), na qual:
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US26719501P | 2001-02-08 | 2001-02-08 | |
US34482402P | 2002-01-07 | 2002-01-07 | |
PCT/US2002/022509 WO2002098878A1 (en) | 2001-02-08 | 2002-02-08 | Trifluoromethylpurines as phosphodiesterase 4 inhibitors |
Publications (1)
Publication Number | Publication Date |
---|---|
BR0207302A true BR0207302A (pt) | 2004-02-10 |
Family
ID=26952286
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR0207302-1A BR0207302A (pt) | 2001-02-08 | 2002-02-08 | Trifluorometilpurinas como inibidores da fosfodiesterase 4 |
Country Status (11)
Country | Link |
---|---|
US (4) | US7342021B2 (pt) |
EP (1) | EP1383767A1 (pt) |
JP (1) | JP4443215B2 (pt) |
KR (1) | KR100863622B1 (pt) |
CN (1) | CN100439370C (pt) |
AU (1) | AU2002313673B2 (pt) |
BR (1) | BR0207302A (pt) |
CA (1) | CA2438099A1 (pt) |
HK (1) | HK1066546A1 (pt) |
MX (1) | MXPA03007134A (pt) |
WO (1) | WO2002098878A1 (pt) |
Families Citing this family (38)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2222614T3 (es) * | 1997-11-12 | 2005-02-01 | Mitsubishi Chemical Corporation | Derivados de purina y medicina que los contiene como ingrediente activo. |
US7342021B2 (en) * | 2001-02-08 | 2008-03-11 | Memory Pharmaceuticals Corp. | Phosphodiesterase 4 inhibitors |
AU2003261418B2 (en) * | 2002-08-08 | 2010-05-27 | Memory Pharmaceuticals Corporation | Phosphodiesterase 4 inhibitors |
WO2004014913A2 (en) * | 2002-08-08 | 2004-02-19 | Memory Pharmaceuticals Corporation | Derivatives of 2-trifluormethyl-6-aminopurine as phosphodiesterase 4 inhibitors |
GB0230045D0 (en) | 2002-12-23 | 2003-01-29 | Glaxo Group Ltd | Compounds |
EP1599468B1 (en) | 2003-01-14 | 2007-10-03 | Arena Pharmaceuticals, Inc. | 1,2,3-trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto such as diabetes and hyperglycemia |
FR2851247B1 (fr) * | 2003-02-19 | 2007-06-29 | Exonhit Therapeutics Sa | Methodes et compositions pour le traitement de pathologies degeneratives oculaires |
FR2856595B1 (fr) * | 2003-06-27 | 2008-05-30 | Exonhit Therapeutics Sa | Methodes et compositions pour le traitement de deficits cognitifs. |
NZ544200A (en) | 2003-07-14 | 2009-07-31 | Arena Pharm Inc | Fused-aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto |
JP2007502776A (ja) * | 2003-08-15 | 2007-02-15 | アイアールエム・リミテッド・ライアビリティ・カンパニー | Rtk阻害剤としての6−置換アニリノプリン類 |
CN100447143C (zh) * | 2003-08-15 | 2008-12-31 | Irm责任有限公司 | 作为rtk抑制剂的6-取代的苯胺基嘌呤 |
CA2548326A1 (en) * | 2003-12-23 | 2005-07-14 | Novartis Ag | Bicyclic heterocyclic p-38 kinase inhibitors |
EP1740590A1 (en) | 2004-03-16 | 2007-01-10 | Glaxo Group Limited | PYRAZOLO [3,4- b] PYRIDINE COMPOUNDS, AND THEIR USE AS PDE4 INHIBITORS |
GB0416699D0 (en) | 2004-07-27 | 2004-09-01 | Prometic Biosciences Ltd | Prion protein ligands and methods of use |
WO2006131768A2 (en) | 2005-06-10 | 2006-12-14 | Prometic Biosciences Limited | Triazines as protein binding ligands |
CN101258144B (zh) | 2005-08-12 | 2012-05-30 | 苏文生命科学有限公司 | 作为功能性5-ht6配体的氨基芳基磺酰胺衍生物 |
WO2007020654A1 (en) | 2005-08-16 | 2007-02-22 | Suven Life Sciences | An improved process for the preparation of losartan |
US8470830B2 (en) | 2007-01-08 | 2013-06-25 | Suven Life Sciences Limited | 5-(heterocyclyl)alkyl-N-(arylsulfonyl)indole compounds and their use as 5-HT6 ligands |
AU2008215948A1 (en) | 2007-02-12 | 2008-08-21 | Merck & Co., Inc. | Piperazine derivatives for treatment of AD and related conditions |
WO2008131501A2 (en) * | 2007-04-27 | 2008-11-06 | Katholieke Universiteit Leuven | New anti-viral nucleoside analogs |
WO2008136017A1 (en) | 2007-05-03 | 2008-11-13 | Suven Life Sciences Limited | Aminoalkoxy aryl sulfonamide compounds and their use as 5-ht6 ligands |
ES2370680T3 (es) | 2007-10-26 | 2011-12-21 | Suven Life Sciences Limited | Compuestos de aminoarilsulfonamida y su empleo como ligandos de 5-ht6. |
US8461389B2 (en) | 2008-04-18 | 2013-06-11 | University College Dublin, National University Of Ireland, Dublin | Psycho-pharmaceuticals |
US8318725B2 (en) | 2008-09-17 | 2012-11-27 | Suven Life Sciences Limited | Aryl indolyl sulfonamide compounds and their use as 5-HT6 ligands |
MX2011002884A (es) | 2008-09-17 | 2011-04-21 | Suven Life Sciences Ltd | Compuestos de aril-sulfonamida-amina y su uso como ligandos de 5-ht6. |
RU2489433C9 (ru) * | 2008-11-27 | 2014-06-10 | Нэшнл Юниверсити Корпорейшн Кагава Юниверсити | Производное циклобутилпурина, агент, активирующий ангиогенез, агент, активирующий образование просвета, агент, активирующий рост нейронов, и лекарственное средство |
SG181992A1 (en) | 2010-01-05 | 2012-08-30 | Suven Life Sciences Ltd | Sulfone compounds as 5-ht6 receptor ligands |
KR101737388B1 (ko) | 2010-02-12 | 2017-05-18 | 에스크엣 인크. | 치매 치료용 5-ht4 수용체 작용제 |
AU2011305525B2 (en) | 2010-09-22 | 2016-08-18 | Arena Pharmaceuticals, Inc. | Modulators of the GPR119 receptor and the treatment of disorders related thereto |
WO2013130461A1 (en) | 2012-02-29 | 2013-09-06 | The Scripps Research Institute | Wee1 degradation inhibitors |
US8865723B2 (en) | 2012-10-25 | 2014-10-21 | Tetra Discovery Partners Llc | Selective PDE4 B inhibition and improvement in cognition in subjects with brain injury |
JP6454346B2 (ja) | 2013-12-20 | 2019-01-16 | サンシャイン・レイク・ファーマ・カンパニー・リミテッドSunshine Lake Pharma Co.,Ltd. | 芳香族複素環式化合物及び医薬におけるその応用 |
MX2021011472A (es) | 2015-01-06 | 2022-08-17 | Arena Pharm Inc | Metodos de condiciones de tratamiento relacionadas con el receptor s1p1. |
PL3310760T3 (pl) | 2015-06-22 | 2023-03-06 | Arena Pharmaceuticals, Inc. | Krystaliczna sól L-argininy kwasu (R)-2-(7-(4-cyklopentylo-3-(trifluorometylo)benzyloksy)- 1,2,3,4-tetrahydrocyklo-penta[b]indol-3-ilo)octowego do zastosowania w zaburzeniach związanych z receptorem S1P1 |
CN110520124A (zh) | 2017-02-16 | 2019-11-29 | 艾尼纳制药公司 | 用于治疗原发性胆汁性胆管炎的化合物和方法 |
CN108395432A (zh) * | 2018-01-15 | 2018-08-14 | 吴江信凯医药科技有限公司 | 一种2-三氟甲基-6-氨基嘌呤的制备方法 |
US20210340122A1 (en) * | 2018-09-05 | 2021-11-04 | University Of Tennessee Research Foundation | Selective androgen receptor degrader (sard) ligands and methods of use thereof |
RU2746012C2 (ru) * | 2019-05-13 | 2021-04-05 | Федеральное государственное бюджетное образовательное учреждение высшего образования "Волгоградский государственный медицинский университет" Министерства здравоохранения Российской Федерации ФГБОУ ВО ВолгГМУ МЗ РФ | Антидепрессантное средство для коррекции нежелательных побочных эффектов нейролептиков |
Family Cites Families (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3917563A (en) | 1970-02-17 | 1975-11-04 | Japan Atomic Energy Res Inst | Process for the production of high molecular weight polyoxymethylene by the polymerization of tetraoxane |
US3919192A (en) * | 1972-05-22 | 1975-11-11 | Icn Pharmaceuticals | 5-Amino-4-substituted imidazole nucleotides |
US3917583A (en) * | 1972-08-04 | 1975-11-04 | Icn Pharmaceuticals | 2-Substituted cyclic AMP derivatives |
AR205247A1 (es) | 1973-02-07 | 1976-04-21 | Icn Pharmaceuticals | Procedimiento para preparar derivados de amp 2-substituidos |
JPS6210085A (ja) | 1985-07-05 | 1987-01-19 | Yoshitomi Pharmaceut Ind Ltd | トリフルオロメチルプリン誘導体 |
JPS62240622A (ja) | 1986-04-11 | 1987-10-21 | Asahi Glass Co Ltd | 抗腫瘍剤 |
GB8817651D0 (en) * | 1988-07-25 | 1988-09-01 | Smith Kline French Lab | Chemical compounds |
US5013829A (en) | 1989-04-26 | 1991-05-07 | University Of Iowa Research Foundation | Stable congener of 2',3'-dideoxyadenosine |
US5935978A (en) * | 1991-01-28 | 1999-08-10 | Rhone-Poulenc Rorer Limited | Compounds containing phenyl linked to aryl or heteroaryl by an aliphatic- or heteroatom-containing linking group |
JP3086912B2 (ja) | 1991-06-20 | 2000-09-11 | 工業技術院長 | フルオロアルキル基含有プリン誘導体及びその製造方法 |
WO1993025517A1 (en) | 1992-06-15 | 1993-12-23 | Celltech Limited | Trisubstituted phenyl derivatives as selective phosphodiesterase iv inhibitors |
DE4230755A1 (de) | 1992-09-14 | 1994-03-17 | Schering Ag | Verwendung von PDE-Inhibitoren bei der Behandlung von Nieren- und Ureter-Erkrankungen |
US5814651A (en) * | 1992-12-02 | 1998-09-29 | Pfizer Inc. | Catechol diethers as selective PDEIV inhibitors |
TW263495B (pt) | 1992-12-23 | 1995-11-21 | Celltech Ltd | |
GB9312853D0 (en) * | 1993-06-22 | 1993-08-04 | Euro Celtique Sa | Chemical compounds |
US5525606A (en) * | 1994-08-01 | 1996-06-11 | The United States Of America As Represented By The Department Of Health And Human Services | Substituted 06-benzylguanines and 6(4)-benzyloxypyrimidines |
US5864037A (en) * | 1996-06-06 | 1999-01-26 | Euro-Celtique, S.A. | Methods for the synthesis of chemical compounds having PDE-IV inhibitory activity |
JPH1072415A (ja) | 1996-06-26 | 1998-03-17 | Nikken Chem Co Ltd | 3−アニリノ−2−シクロアルケノン誘導体 |
US5744473A (en) * | 1996-09-16 | 1998-04-28 | Euro-Celtique, S.A. | PDE IV inhibitors: "bis-compounds" |
DE19702785A1 (de) | 1997-01-27 | 1998-07-30 | Bayer Ag | Neue cyclische Harnstoffderivate |
EP0994100B1 (en) | 1997-06-24 | 2006-08-30 | Nikken Chemicals Company, Limited | 3-anilino-2-cycloalkenone derivates |
ES2222614T3 (es) | 1997-11-12 | 2005-02-01 | Mitsubishi Chemical Corporation | Derivados de purina y medicina que los contiene como ingrediente activo. |
HUP0301166A2 (en) * | 1997-12-12 | 2003-08-28 | Euro Celtique Sa | 3-substituted adenines via2-thioxanthines |
JP4160645B2 (ja) | 1997-12-24 | 2008-10-01 | 大日本住友製薬株式会社 | 新規アデニン誘導体及びその医薬用途 |
JP3542482B2 (ja) | 1997-12-25 | 2004-07-14 | 日研化学株式会社 | 3−アニリノ−2−シクロアルケノン誘導体 |
JPH11264847A (ja) | 1998-03-18 | 1999-09-28 | Advantest Corp | スペクトラム・アナライザ |
JP2000072773A (ja) | 1998-08-28 | 2000-03-07 | Zeria Pharmaceut Co Ltd | プリン誘導体 |
US6319928B1 (en) * | 1998-11-30 | 2001-11-20 | Euro-Celtique, S.A. | Purine derivatives having phosphodiesterase IV inhibition activity |
DE19935209A1 (de) | 1999-07-27 | 2001-02-08 | Truss Michael C | Verwendung von Substanzen, die den intrazellulären Gehalt von zyklischem Adenosinmonophosphat (cAMP) erhöhen oder die Aktivität cAMP-bindender Proteine stimulieren, zur Behandlung von Erkrankungen der Harnblase |
GB0011802D0 (en) | 2000-05-16 | 2000-07-05 | Smithkline Beecham | Method for enhancing cognitive function |
US7342021B2 (en) | 2001-02-08 | 2008-03-11 | Memory Pharmaceuticals Corp. | Phosphodiesterase 4 inhibitors |
AU2003261418B2 (en) * | 2002-08-08 | 2010-05-27 | Memory Pharmaceuticals Corporation | Phosphodiesterase 4 inhibitors |
WO2004014913A2 (en) * | 2002-08-08 | 2004-02-19 | Memory Pharmaceuticals Corporation | Derivatives of 2-trifluormethyl-6-aminopurine as phosphodiesterase 4 inhibitors |
US7371737B2 (en) * | 2004-09-09 | 2008-05-13 | Solvay Pharmaceuticals, B.V. | 2-substituted-6-trifluoromethyl purine derivatives with adenosine-A3 antagonistic activity |
-
2002
- 2002-02-08 US US10/067,996 patent/US7342021B2/en not_active Expired - Fee Related
- 2002-02-08 WO PCT/US2002/022509 patent/WO2002098878A1/en active IP Right Grant
- 2002-02-08 CN CNB02807890XA patent/CN100439370C/zh not_active Expired - Fee Related
- 2002-02-08 JP JP2003501999A patent/JP4443215B2/ja not_active Expired - Fee Related
- 2002-02-08 EP EP02753379A patent/EP1383767A1/en not_active Withdrawn
- 2002-02-08 CA CA002438099A patent/CA2438099A1/en not_active Abandoned
- 2002-02-08 AU AU2002313673A patent/AU2002313673B2/en not_active Ceased
- 2002-02-08 BR BR0207302-1A patent/BR0207302A/pt not_active IP Right Cessation
- 2002-02-08 MX MXPA03007134A patent/MXPA03007134A/es active IP Right Grant
- 2002-02-08 KR KR1020037010420A patent/KR100863622B1/ko not_active IP Right Cessation
-
2004
- 2004-05-14 US US10/845,354 patent/US20040242598A1/en not_active Abandoned
- 2004-12-01 HK HK04109532.2A patent/HK1066546A1/xx not_active IP Right Cessation
-
2007
- 2007-12-14 US US11/956,871 patent/US20080119495A1/en not_active Abandoned
-
2009
- 2009-09-22 US US12/564,636 patent/US20100010020A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US20040242598A1 (en) | 2004-12-02 |
AU2002313673B2 (en) | 2006-09-07 |
KR20040008127A (ko) | 2004-01-28 |
HK1066546A1 (en) | 2005-03-24 |
EP1383767A1 (en) | 2004-01-28 |
US7342021B2 (en) | 2008-03-11 |
JP2004528391A (ja) | 2004-09-16 |
US20080119495A1 (en) | 2008-05-22 |
JP4443215B2 (ja) | 2010-03-31 |
CN1501927A (zh) | 2004-06-02 |
CA2438099A1 (en) | 2002-12-12 |
US20100010020A1 (en) | 2010-01-14 |
WO2002098878A1 (en) | 2002-12-12 |
KR100863622B1 (ko) | 2008-10-15 |
CN100439370C (zh) | 2008-12-03 |
MXPA03007134A (es) | 2004-10-15 |
US20030045533A1 (en) | 2003-03-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR0207302A (pt) | Trifluorometilpurinas como inibidores da fosfodiesterase 4 | |
BRPI0416869A (pt) | 5,7-diaminopirazolo '4,3-dipirimidinas com atividade de inibição de pde-5 | |
DE60336850D1 (en) | Substituierte arylcyclopropylacetamide als glucokinaseaktivatoren | |
BR0207278A (pt) | Derivados de ftalazinona-piperidina como inibidores de pde4 | |
BR0208062A (pt) | Inibidores de metaloproteinase | |
BR0207983A (pt) | Inibidores de metaloproteinase | |
AP1753A (en) | Thiophene derivatives as antiviral agents for flavvivirus infection | |
TW200602322A (en) | Phosphodiesterase 4 inhibitors, including n-substituted diarylamine analogs | |
CY1113362T1 (el) | Διαρυλ-αιθερες, ως ανταγωνιστης οπιοειδους υποδοχεως | |
CY1106247T1 (el) | Θειοφαινο- και θειαζολοσουλφοναμιδες ως αντινεοπλαστικοι παραγοντες | |
SE0000540D0 (sv) | New compounds | |
BR0214268A (pt) | Aperfeiçoamentos em relação a abrilhantadores ópticos | |
UY28290A1 (es) | Compuestos farmacéuticos novedosos | |
WO2001019828A3 (en) | Kinase inhibitors as therapeutic agents | |
DE60107449D1 (de) | Substituierte aminopropoxyarylderivate als lxr agonisten | |
ATE449099T1 (de) | Derivate des 2-trifluormethyl-6-aminopurins als phosphodiesterase 4 inhibitoren | |
BR0313969A (pt) | Inibidores de oxitocina | |
NO20050871L (no) | 6-amino-1H-indazol- og 4-aminobenzofuranforbindelser som fosfodiesterase 4-inhibitorer | |
ATE411287T1 (de) | Neue metallproteinaseinhibitoren | |
DK1448562T3 (da) | Substituerede tetracycliske pyrroloquinolonderivater egnede som phosphodiesteraseinhibitorer | |
BR0208812A (pt) | Derivados fenil heterociclil éter como inibidores de recaptação de serotonina | |
NO20040388L (no) | Fremgangsmåte for fremstilling av beraprost og salter derav, samt forbindelser som er mellomprodukter i fremgangsmåten | |
BG107003A (en) | Piperidine- and piperazine substituted n-hydroxyformamides as inhibitors of metalloproteinases | |
BRPI0416678A (pt) | pirazolpirimidinas | |
EA200301101A1 (ru) | Производные пиперазина и их применение в качестве ингибиторов pde4 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B07A | Technical examination (opinion): publication of technical examination (opinion) [chapter 7.1 patent gazette] | ||
B09B | Patent application refused [chapter 9.2 patent gazette] | ||
B08F | Application fees: application dismissed [chapter 8.6 patent gazette] |
Free format text: REFERENTE 10A. ANUIDADE(S), |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2144 DE 07/02/2012. |